Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical Trial

Constantin‐Cristian Topriceanu(Barts Health NHS Trust), Carolyn Y. Ho(Brigham and Women's Hospital), James Moon(Virginia Mason Medical Center), Charles E. Canter, Anna Axelsson Raja(Copenhagen University Hospital), Christine E. Seidman(Brigham and Women's Hospital), Christoffer Rasmus Vissing(Copenhagen University Hospital), Ivan Wilmot(Cincinnati Children's Hospital Medical Center), Usman A. Tahir(Beth Israel Deaconess Medical Center), Joseph W. Rossano(Children's Hospital of Philadelphia), Alexandre C. Pereira(University of Washington), Anjali Owens(University of Pennsylvania), Amit R. Patel(University of Chicago Medical Center), Jonathan H. Soslow(Vanderbilt University Medical Center), Gabriella Captur(The Royal Free Hospital), Henning Bundgaard, Neal K. Lakdawala(Brigham and Women's Hospital), Matthew T. Wheeler(Stanford University), Kenneth Zahka(Cleveland Clinic), Jason R. Becker(Vanderbilt University), Matthew R.G. Taylor(University of Colorado Anschutz Medical Campus), Luisa Mestroni(University of Colorado Anschutz Medical Campus), Sharlene M. Day(Cardiovascular Institute of the South), Richard G. Bach(Washington University in St. Louis), Steven D. Colan, Mark W. Russell(University of Michigan), Anne M. Murphy(Johns Hopkins University)
Circulation Heart Failure
May 9, 2025
Cited by 3


Related Papers